MedPhab offers modular technology blocks including photonics technologies, non-photonic peripherals, system integration and post-processing steps. This modular concept enables a structured approach to highly fragmented heterogeneous photonic and non-photonic technologies such as microfluidics or surface functionalization from early phase proof-of-concept to regulated pilot production. The photonics technologies offering within MedPhab comprises fiber optics, photonic reader modules, photonic integrated circuits, micro-optics and active components provided by parties with ISO13485 certificate.

The technology offered by MedPhab can help companies to develop diagnostic solutions for hospital use to enable real-time information and monitoring of the treatment progression; novel home care services, and equipment for molecular diagnostics based on serum, saliva or urine samples.

The MedPhab Open Call provides financial support for pioneer business cases. European-based SMEs may receive a subsidy of 75 % of their innovation project, whereas large-scale European companies receive a 50% subsidy. The first cut-off date for expressing your interest is July 15^th, 2021.

MedPhab has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871345. To learn more about MedPhab and the Open Call, visit www.medphab.eu / www.photonics21.org